Agilent Technologies, Inc.: Form 10-Q for the period ended Jan 31, 2024
Filed with the SEC on Mar 5, 2024 and accepted by EDGAR at Mar 4, 2024, 18:49 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-01-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-11-01 to 2024-01-31 | $1.66bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-11-01 to 2024-01-31 | $750.0m | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months2023-11-01 to 2024-01-31 | $128.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-11-01 to 2024-01-31 | $396.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-11-01 to 2024-01-31 | $384.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-11-01 to 2024-01-31 | $22.0m | us-gaap:InterestExpense |
| Income tax | 3 months2023-11-01 to 2024-01-31 | $55.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-11-01 to 2024-01-31 | $348.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-11-01 to 2024-01-31 | $1.18 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-11-01 to 2024-01-31 | $1.19 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-11-01 to 2024-01-31 | 294,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-11-01 to 2024-01-31 | $485.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-11-01 to 2024-01-31 | $90.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2023-11-01 to 2024-01-31 | $69.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2023-11-01 to 2024-01-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-01-31 | $1.75bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-01-31 | $4.34bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-01-31 | $10.95bn | us-gaap:Assets |
| Current liabilities | At period end2024-01-31 | $1.62bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-01-31 | $4.76bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-01-31 | $2.56bn | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2024-01-31 | $6.19bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001090872-24-000011. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.